ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Revance Therapeutics Inc

Revance Therapeutics Inc (RVNC)

3.92
0.16
(4.26%)
Closed July 26 3:00PM
3.9406
0.0206
(0.53%)
After Hours: 6:35PM

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 28.37M29.02M49.92M49.33M58.13M56.78M69.8M51.94M
Operating Income -57.84M-77.48M-144.41M-58.03M-65.5M-139.29M-53.95M-46.83M
Pre Tax Income -61.44M-83.99M-145.95M-59.79M-67.32M-140.88M-55.7M-49.53M
Net Income -61.44M-84.69M-145.95M-59.79M-67.32M-141.18M-55.7M-53.15M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -58.12M-77.37M-146.21M-58.27M-66.1M-139.52M-53.74M-47.27M
EBITDA -52.39M-72.05M-57.16M-51.41M-61.97M-43.99M-52.53M-44.85M
Year End December 30 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 300k262k3.73M413k15.33M77.8M132.57M234.04M
Operating Income -79.16M-117.5M-142.63M-164.46M-273.16M-274.68M-341.96M-316.78M
Pre Tax Income -89.27M-120.59M-139.57M-159.43M-284.71M-281.31M-355.72M-323.69M
Net Income -89.27M-120.59M-142.57M-159.43M-282.09M-281.31M-356.42M-323.99M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -3.156-3.302-3.856-3.044-4.078-3.93-4.326-3.689
EBIT -79.69M-118.02M-143.41M-164.76M-273.75M-275.44M-344.14M-317.62M
EBITDA -77.71M-116M-140.91M-161.55M-262.91M-254.82M-238.44M-209.9M